Immunosenescence, a decline in immune function that occurs with age, is a
major hurdle to successful vaccination in older people. In this chapter, the relationship
between immunosenescence and mucosal vaccination is investigated, highlighting fresh
approaches to improving immune protection in older adults. Dramatic changes take
place in the immune system when individuals grow older, as it undergoes reduced T
cell functioning and B cell responses that impede and dysregulated inflammatory
processes. With these changes, vaccines become less effective, and old people become
more susceptible to infections. Traditional parenteral vaccines often do not produce
strong immune responses in this group, so vaccine efficacy needs to be improved
through different means. For instance, mucosal vaccination could be a solution to
overcome immunosenescence-induced obstacles. Mucosal vaccines induce local and
systemic immune reactions by targeting the respiratory tracts and alimentary canal. As
such, they have the potential to offer wider protection from respiratory pathogens. This
abstract examines the mechanisms of mucosal vaccinations and their potential to
induce strong immunity even in older individuals who are susceptible to diseases.
Clinical research has demonstrated that immunization using this method is effective
among older adults, thereby proving that it is better than most traditional injections in
particular instances. However, there are still obstacles, such as how to administer these
vaccines safely and regulatory aspects, which calls for more investigation and
creativity in this area. The promise of elevating immunization protection in old people
is achieved by the integration of mucosal vaccination into geriatric healthcare practices.
By using specific vaccine strategies for addressing Immunosenescence, healthcare providers can reduce the prevalence of vaccine-preventable diseases and improve overall
health outcomes in aged populations. To sum it up, this abstract emphasizes the need to
understand immunosenescence and assesses mucosal vaccination as a way to fill an
immunity gap among elderly patients. In research, policy, and clinical practice
collaborations, we can make headways toward a future where immunity is not
restricted by age.
Keywords: Antibody, Adaptive response, B-cell, Dysregulation, Elderly patients, Mucosal vaccination, Immune system, Inflammation, Immunosenescence, Infections, Parenteral vaccine, Respiratory pathogens, T-cell.
